Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02059892
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
ETS | (4S-TRANS)-4-(ETHYLAMINO)-5,6-DIHYDRO- 6-METHYL-4H-THIENO(2,3-B)THIOPYRAN- 2-SULFONAMIDE-7,7-DIOXIDE | A | 1CIL | 0.76 | |
C71 | N-[4-(AMINOMETHYL)-1,1-DIOXIDOTETRAHYDRO- 2H-THIOPYRAN-4-YL]-3-(1-METHYLCYCLOPENTYL)- N~2~-[(1E)-N-(PHENYLSULFONYL)ETHANIMIDOYL]- L-ALANINAMIDE | A,B | 2FRQ | 0.71 | |
AL4 | (R)-4-ETHYLAMINO-3,4-DIHYDRO-2- (2-METHOYLETHYL)-2H-THIENO[3,2- E]-1,2-THIAZINE-6-SULFONAMIDE-1,1- DIOXIDE | A | 1BNQ | 0.71 | |
TP2 | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | A,B | 1F4D | 0.78 | |
TP2 | N-[TOSYL-D-PROLINYL]AMINO-ETHANETHIOL | A,B | 1F4C | 0.78 | |
C1P | N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~- [(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP- 2-ENYL]-D-LEUCINAMIDE | A,B,C,D | 3BWK | 0.71 | |
C1P | N~2~-(MORPHOLIN-4-YLCARBONYL)-N~1~- [(1S,2E)-1-(2-PHENYLETHYL)-3-(PHENYLSULFONYL)PROP- 2-ENYL]-D-LEUCINAMIDE | A,B | 1NPZ | 0.71 | |
BZ1 | (+)-4-ETHYLAMINO-3,4-DIHYDRO-2- (METHOXY)PROPYL-2H-THIENO[3,2-E]- 1,2-THIAZINE-6-SULFONAMIDE-1,1- DIOXIDE | A | 3ZNC | 0.72 | |
53U | D-phenylalanyl-N-benzyl-L-prolinamide | H,I | 2ZFF | 0.7 | |
R56 | 5-OXO-6-PHENYLMETHANESULFONYLAMINO- HEXAHYDRO-THIAZOLO[3,2-A]PYRIDINE- 3-CARBOXYLIC ACID (3-GUANIDINO- PROPYL)-AMIDE | F | 1BHX | 0.7 | |
F20 | N-BENZOYL-L-PHENYLALANYL-4-[(5S)- 1,1-DIOXIDO-3-OXOISOTHIAZOLIDIN- 5-YL]-L-PHENYLALANINAMIDE | A | 2CMA | 0.73 | |
AL5 | THIOPHENE-2,5-DISULFONIC ACID 2- AMIDE-5-(4-METHYL-BENZYLAMIDE) | A | 1BN1 | 0.76 | |
CRJ | N-(1-CYANOCYCLOPROPYL)-3-({[(2S)- 5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)- N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4- FLUOROPHENYL)ETHYL]-L-ALANINAMIDE | A,B | 2FQ9 | 0.75 | |
521 | 5-(4-CHLORO-5-PHENYL-3-THIENYL)- 1,2,5-THIADIAZOLIDIN-3-ONE 1,1- DIOXIDE | A | 2NTA | 0.73 | |
MZ1 | N~2~-ACETYL-N-[(1S,2R)-1-BENZYL- 2-HYDROXY-3-{(2-THIENYLMETHYL)[(2,4,5- TRIFLUOROPHENYL)SULFONYL]AMINO}PROPYL]- L-ALANINAMIDE | A,B | 2QHY | 0.8 | |
3SP | N-(CARBOXYMETHYL)-3-CYCLOHEXYL- D-ALANYL-N-({5-[(E)-AMINO(IMINO)METHYL]THIEN- 2-YL}METHYL)-L-PROLINAMIDE | D,H | 2FES | 0.72 | |
F21 | (3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN- 4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE | A,B | 2G72 | 0.71 | |
F21 | (3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN- 4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE | A,B | 2OPB | 0.71 | |
160 | 3-(3-{2-[(5-METHANESULFONYL-THIOPHENE- 2-CARBONYL)-AMINO]-ETHYLDISULFANYLMETHYL}- BENZENESULFONYLAMINO)-4-OXO-PENTANOIC ACID | A,B | 1NMQ | 0.77 | |
IZD | ISOTHIAZOLIDINONE ANALOG | A | 2CM7 | 0.75 | |
7XY | {(3-CHLOROBENZYL)[(5-{[(3,3-DIPHENYLPROPYL)AMINO]SULFONYL}- 2-THIENYL)METHYL]AMINO}(OXO)ACETIC ACID | A,B | 2OZ5 | 0.74 | |
GSX | 5'-CHLORO-N-{(3S)-1-[(1S)-1-METHYL- 2-MORPHOLIN-4-YL-2-OXOETHYL]-2- OXOPYRROLIDIN-3-YL}-2,2'-BITHIOPHENE- 5-SULFONAMIDE | A | 2J95 | 0.7 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1JK3 | 0.81 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1MMB | 0.81 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 2RJQ | 0.81 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A | 1RM8 | 0.81 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A,B | 2J83 | 0.81 | |
BAT | 4-(N-HYDROXYAMINO)-2R-ISOBUTYL- 2S-(2-THIENYLTHIOMETHYL)SUCCINYL- L-PHENYLALANINE-N-METHYLAMIDE | A,B | 1DTH | 0.81 | |
PTS | (4S-TRANS)-4-(AMINO)-5,6-DIHYDRO- 6-METHYL-4H-THIENO (2,3-B)THIOPYRAN- 2-SULFONAMIDE-7,7-DIOXIDE | A | 1CIM | 0.71 | |
GS5 | 5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL- 2-MORPHOLIN-4-YL-2-OXOETHYL]-2- OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE- 2-SULFONAMIDE | A | 2J38 | 0.73 | |
QN2 | N,N'-(3S,4S)-pyrrolidine-3,4-diylbis[N- (4-iodobenzyl)benzenesulfonamide] | A,B | 2QNP | 0.71 | |
4MC | (Z)-N-(5-GUANIDINO-1-OXO-1-(5-PHENYL- 1-(PHENYLSULFONYL)PENT-1-EN-3-YLAMINO)PENTAN- 2-YL)-4-METHYLPIPERAZINE-1-CARBOXAMIDE | A,C | 2EFM | 0.72 | |
GS6 | 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL- 2-MORPHOLIN-4-YL-2-OXOETHYL]-2- OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE- 2-SULFONAMIDE | A | 2J34 | 0.73 | |
GSV | 2-(5-chlorothiophen-2-yl)-N-{(3S)- 1-[3-fluoro-2'-(methylsulfonyl)biphenyl- 4-yl]-2-oxopyrrolidin-3-yl}ethanesulfonamide | A | 2VH6 | 0.75 | |
T29 | TRI166 (BIFUNCTIONAL BORONATE INHIBITOR) | H | 1A3B | 0.7 | |
G0G | N,N'-(3S,4S)-PYRROLIDINE-3,4-DIYLBIS(N- BENZYLBENZENESULFONAMIDE) | A,B | 2PQZ | 0.73 | |
MTS | (4S-TRANS)-4-(METHYLAMINO)-5,6- DIHYDRO-6-METHYL-4H-THIENO(2,3- B)THIOPYRAN-2-SULFONAMIDE-7,7-DIOXIDE | A | 1CIN | 0.75 | |
M25 | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | A,B | 2NMX | 0.72 | |
M25 | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | A | 2NNS | 0.72 | |
YDP | (3S,4S),-3,4-Bis-[(4-carbamoyl- benzensulfonyl)-(3-methyl-but-2- enyl)-amino]-pyrrolidine | A | 2ZGA | 0.72 | |
YDP | (3S,4S),-3,4-Bis-[(4-carbamoyl- benzensulfonyl)-(3-methyl-but-2- enyl)-amino]-pyrrolidine | A,B | 3CKT | 0.72 | |
BZU | (4R)-2-(2-ethoxyethyl)-4-(ethylamino)- 3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine- 6-sulfonamide 1,1-dioxide | A | 1A42 | 0.7 | |
NFT | N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'- (AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2- TRIFLUOROETHYL}-L-LEUCINAMIDE | A | 1VSN | 0.75 | |
SUB | 3-PHENYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PROPIONIC ACID ETHYL ESTER | A | 1J4H | 0.71 | |
SM4 | (1R)-1-(2-THIOPHEN-2-YL-ACETYLAMINO)- 1-(3-(2-CARBOXYVINYL)-PHENYL) METHYLBORONIC ACID | A,B | 2RCX | 0.72 | |
D1R | NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]- N-{(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}- L-PHENYLALANINAMIDE | A | 2P7U | 0.72 | |
D1R | NALPHA-[(4-METHYLPIPERAZIN-1-YL)CARBONYL]- N-{(1S)-3-PHENYL-1-[2-(PHENYLSULFONYL)ETHYL]PROPYL}- L-PHENYLALANINAMIDE | A,C | 2OZ2 | 0.72 | |
TST | 4-METHYL-2-{[4-(TOLUENE-4-SULFONYL)- THIOMORPHOLINE-3-CARBONYL]-AMINO}- PENTANOIC ACID | A | 1J4I | 0.72 | |
SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 1PI4 | 0.77 | |
SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 2FFY | 0.77 | |
SM3 | (1R)-1-(2-THIENYLACETYLAMINO)-1- PHENYLMETHYLBORONIC ACID | A,B | 1MY8 | 0.77 | |
3CC | N-[(2R)-5-(aminosulfonyl)-2,3-dihydro- 1H-inden-2-yl]-2-propylpentanamide | A | 2QO8 | 0.73 | |
G23 | (2R,4S)-2-[(R)-BENZYLCARBAMOYL- PHENYLACETYL-METHYL]-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | A | 1HTE | 0.72 | |
MZ2 | (2E)-N-[(1S,2R)-1-BENZYL-2-HYDROXY- 3-{(2-THIENYLMETHYL)[(2,4,5-TRIFLUOROPHENYL)SULFONYL]AMINO}PROPYL]- 4,4,4-TRIFLUORO-3-METHYLBUT-2-ENAMIDE | A,B | 2QHZ | 0.76 | |
RA8 | N-(BENZYLSULFONYL)-L-LEUCYL-N-(4- {[AMINO(IMINO)METHYL]AMINO}BUTYL)- L-PROLINAMIDE | H,I | 1YPL | 0.7 | |
701 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}PROPENE-1-SULFONAMIDE | D,H | 2JH0 | 0.7 | |
701 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}PROPENE-1-SULFONAMIDE | A | 2UWO | 0.7 |